1. Home
  2. AGIO vs JKS Comparison

AGIO vs JKS Comparison

Compare AGIO & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.43

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$23.31

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
JKS
Founded
2007
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
AGIO
JKS
Price
$27.43
$23.31
Analyst Decision
Buy
Sell
Analyst Count
8
3
Target Price
$37.63
$22.33
AVG Volume (30 Days)
791.9K
489.4K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
5.46%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
N/A
Revenue This Year
$75.68
N/A
Revenue Next Year
$167.63
$37.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$13.42
52 Week High
$46.00
$31.88

Technical Indicators

Market Signals
Indicator
AGIO
JKS
Relative Strength Index (RSI) 42.16 35.28
Support Level $26.40 $21.38
Resistance Level $29.49 $23.76
Average True Range (ATR) 1.18 1.02
MACD -0.19 -0.37
Stochastic Oscillator 14.64 2.89

Price Performance

Historical Comparison
AGIO
JKS

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.

Share on Social Networks: